| Type |
Details |
Score |
| Publication |
| First Author: |
Corliss BA |
| Year: |
2020 |
| Journal: |
Diabetes |
| Title: |
Pericyte Bridges in Homeostasis and Hyperglycemia. |
| Volume: |
69 |
| Issue: |
7 |
| Pages: |
1503-1517 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ji X |
| Year: |
2023 |
| Journal: |
Cell Chem Biol |
| Title: |
Genetic activation of glycolysis in osteoblasts preserves bone mass in type I diabetes. |
| Volume: |
30 |
| Issue: |
9 |
| Pages: |
1053-1063.e5 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kakoki M |
| Year: |
2019 |
| Journal: |
JCI Insight |
| Title: |
Engulfment and cell motility protein 1 potentiates diabetic cardiomyopathy via Rac-dependent and Rac-independent ROS production. |
| Volume: |
4 |
| Issue: |
12 |
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wang L |
| Year: |
2017 |
| Journal: |
Am J Physiol Renal Physiol |
| Title: |
Podocyte-specific knockout of cyclooxygenase 2 exacerbates diabetic kidney disease. |
| Volume: |
313 |
| Issue: |
2 |
| Pages: |
F430-F439 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Li K |
| Year: |
2022 |
| Journal: |
FASEB J |
| Title: |
Impaired glucose metabolism underlies articular cartilage degeneration in osteoarthritis. |
| Volume: |
36 |
| Issue: |
6 |
| Pages: |
e22377 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kogot-Levin A |
| Year: |
2020 |
| Journal: |
Cell Rep |
| Title: |
Proximal Tubule mTORC1 Is a Central Player in the Pathophysiology of Diabetic Nephropathy and Its Correction by SGLT2 Inhibitors. |
| Volume: |
32 |
| Issue: |
4 |
| Pages: |
107954 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kwong LN |
| Year: |
2015 |
| Journal: |
J Clin Invest |
| Title: |
Co-clinical assessment identifies patterns of BRAF inhibitor resistance in melanoma. |
| Volume: |
125 |
| Issue: |
4 |
| Pages: |
1459-70 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Fufa TD |
| Year: |
2015 |
| Journal: |
Hum Mol Genet |
| Title: |
Genomic analysis reveals distinct mechanisms and functional classes of SOX10-regulated genes in melanocytes. |
| Volume: |
24 |
| Issue: |
19 |
| Pages: |
5433-50 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Held MA |
| Year: |
2010 |
| Journal: |
Cancer Res |
| Title: |
Characterization of melanoma cells capable of propagating tumors from a single cell. |
| Volume: |
70 |
| Issue: |
1 |
| Pages: |
388-97 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Delmas V |
| Year: |
2007 |
| Journal: |
Genes Dev |
| Title: |
Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development. |
| Volume: |
21 |
| Issue: |
22 |
| Pages: |
2923-35 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hill KS |
| Year: |
2019 |
| Journal: |
Mol Cancer Res |
| Title: |
PTPN11 Plays Oncogenic Roles and Is a Therapeutic Target for BRAF Wild-Type Melanomas. |
| Volume: |
17 |
| Issue: |
2 |
| Pages: |
583-593 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Reinitz F |
| Year: |
2022 |
| Journal: |
Elife |
| Title: |
Inhibiting USP16 rescues stem cell aging and memory in an Alzheimer's model. |
| Volume: |
11 |
|
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Uka R |
| Year: |
2020 |
| Journal: |
Oncogene |
| Title: |
Temporal activation of WNT/β-catenin signaling is sufficient to inhibit SOX10 expression and block melanoma growth. |
| Volume: |
39 |
| Issue: |
20 |
| Pages: |
4132-4154 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Liu W |
| Year: |
2012 |
| Journal: |
Cancer Cell |
| Title: |
LKB1/STK11 inactivation leads to expansion of a prometastatic tumor subpopulation in melanoma. |
| Volume: |
21 |
| Issue: |
6 |
| Pages: |
751-64 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Schaefer SM |
| Year: |
2017 |
| Journal: |
Oncogene |
| Title: |
Sox2 is dispensable for primary melanoma and metastasis formation. |
| Volume: |
36 |
| Issue: |
31 |
| Pages: |
4516-4524 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zingg D |
| Year: |
2015 |
| Journal: |
Nat Commun |
| Title: |
The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors. |
| Volume: |
6 |
|
| Pages: |
6051 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Rai K |
| Year: |
2015 |
| Journal: |
Cancer Discov |
| Title: |
Dual Roles of RNF2 in Melanoma Progression. |
| Volume: |
5 |
| Issue: |
12 |
| Pages: |
1314-27 |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
mutant stock, targeted mutation, transgenic |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Harris ML |
| Year: |
2013 |
| Journal: |
PLoS Genet |
| Title: |
A dual role for SOX10 in the maintenance of the postnatal melanocyte lineage and the differentiation of melanocyte stem cell progenitors. |
| Volume: |
9 |
| Issue: |
7 |
| Pages: |
e1003644 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Huang JL |
| Year: |
2015 |
| Journal: |
Cancer Res |
| Title: |
Oncogenic G Protein GNAQ Induces Uveal Melanoma and Intravasation in Mice. |
| Volume: |
75 |
| Issue: |
16 |
| Pages: |
3384-97 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Damsky W |
| Year: |
2015 |
| Journal: |
Cancer Cell |
| Title: |
mTORC1 activation blocks BrafV600E-induced growth arrest but is insufficient for melanoma formation. |
| Volume: |
27 |
| Issue: |
1 |
| Pages: |
41-56 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Tonks ID |
| Year: |
2017 |
| Journal: |
Oncogene |
| Title: |
Melanocyte transformation requires complete loss of all pocket protein function via a mechanism that mitigates the need for MAPK pathway activation. |
| Volume: |
36 |
| Issue: |
26 |
| Pages: |
3789-3795 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yu Y |
| Year: |
2018 |
| Journal: |
Cancer Cell |
| Title: |
Targeting the Senescence-Overriding Cooperative Activity of Structurally Unrelated H3K9 Demethylases in Melanoma. |
| Volume: |
33 |
| Issue: |
2 |
| Pages: |
322-336.e8 |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
transgenic, targeted mutation, mutant strain, congenic |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Le HH |
| Year: |
2021 |
| Journal: |
EBioMedicine |
| Title: |
Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells. |
| Volume: |
73 |
|
| Pages: |
103646 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bonet C |
| Year: |
2017 |
| Journal: |
J Natl Cancer Inst |
| Title: |
Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression. |
| Volume: |
109 |
| Issue: |
8 |
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zhai Y |
| Year: |
2020 |
| Journal: |
Pigment Cell Melanoma Res |
| Title: |
Differences in tumor initiation and progression of melanoma in the BrafCA ;Tyr-CreERT2;Ptenf/f model between male and female mice. |
| Volume: |
33 |
| Issue: |
1 |
| Pages: |
119-121 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zhao F |
| Year: |
2018 |
| Journal: |
Cancer Immunol Res |
| Title: |
Stromal Fibroblasts Mediate Anti-PD-1 Resistance via MMP-9 and Dictate TGFβ Inhibitor Sequencing in Melanoma. |
| Volume: |
6 |
| Issue: |
12 |
| Pages: |
1459-1471 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chhabra G |
| Year: |
2022 |
| Journal: |
J Invest Dermatol |
| Title: |
Antimelanoma Effects of Concomitant Inhibition of SIRT1 and SIRT3 in Braf(V600E)/Pten(NULL) Mice. |
| Volume: |
142 |
| Issue: |
4 |
| Pages: |
1145-1157.e7 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ishak Gabra MB |
| Year: |
2020 |
| Journal: |
Nat Commun |
| Title: |
Dietary glutamine supplementation suppresses epigenetically-activated oncogenic pathways to inhibit melanoma tumour growth. |
| Volume: |
11 |
| Issue: |
1 |
| Pages: |
3326 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
RodrÃguez CI |
| Year: |
2018 |
| Journal: |
Cancer Lett |
| Title: |
Elevated cyclic AMP levels promote BRAFCA/Pten-/- mouse melanoma growth but pCREB is negatively correlated with human melanoma progression. |
| Volume: |
414 |
|
| Pages: |
268-277 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Spitzer MH |
| Year: |
2017 |
| Journal: |
Cell |
| Title: |
Systemic Immunity Is Required for Effective Cancer Immunotherapy. |
| Volume: |
168 |
| Issue: |
3 |
| Pages: |
487-502.e15 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Niu L |
| Year: |
2024 |
| Journal: |
Sci Adv |
| Title: |
Noncovalently particle-anchored cytokines with prolonged tumor retention safely elicit potent antitumor immunity. |
| Volume: |
10 |
| Issue: |
16 |
| Pages: |
eadk7695 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ferretti R |
| Year: |
2016 |
| Journal: |
Genes Dev |
| Title: |
BMI1 induces an invasive signature in melanoma that promotes metastasis and chemoresistance. |
| Volume: |
30 |
| Issue: |
1 |
| Pages: |
18-33 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
RodrÃguez CI |
| Year: |
2017 |
| Journal: |
Mol Cancer Res |
| Title: |
EPAC-RAP1 Axis-Mediated Switch in the Response of Primary and Metastatic Melanoma to Cyclic AMP. |
| Volume: |
15 |
| Issue: |
12 |
| Pages: |
1792-1802 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Mikheil D |
| Year: |
2023 |
| Journal: |
Cancers (Basel) |
| Title: |
Notch Signaling Suppresses Melanoma Tumor Development in BRAF/Pten Mice. |
| Volume: |
15 |
| Issue: |
2 |
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Jahid S |
| Year: |
2022 |
| Journal: |
Cell Rep |
| Title: |
Structure-based design of CDC42 effector interaction inhibitors for the treatment of cancer. |
| Volume: |
39 |
| Issue: |
1 |
| Pages: |
110641 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bagati A |
| Year: |
2019 |
| Journal: |
Oncogene |
| Title: |
KLF9-dependent ROS regulate melanoma progression in stage-specific manner. |
| Volume: |
38 |
| Issue: |
19 |
| Pages: |
3585-3597 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Neubert NJ |
| Year: |
2018 |
| Journal: |
Sci Transl Med |
| Title: |
T cell-induced CSF1 promotes melanoma resistance to PD1 blockade. |
| Volume: |
10 |
| Issue: |
436 |
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hanna SC |
| Year: |
2013 |
| Journal: |
J Clin Invest |
| Title: |
HIF1α and HIF2α independently activate SRC to promote melanoma metastases. |
| Volume: |
123 |
| Issue: |
5 |
| Pages: |
2078-93 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Choi YS |
| Year: |
2022 |
| Journal: |
Cell |
| Title: |
Topical therapy for regression and melanoma prevention of congenital giant nevi. |
| Volume: |
185 |
| Issue: |
12 |
| Pages: |
2071-2085.e12 |
|
•
•
•
•
•
|
| Strain |
| Attribute String: |
transgenic, targeted mutation, mutant strain, congenic |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ni TK |
| Year: |
2013 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Low-copy piggyBac transposon mutagenesis in mice identifies genes driving melanoma. |
| Volume: |
110 |
| Issue: |
38 |
| Pages: |
E3640-9 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Vittoria MA |
| Year: |
2022 |
| Journal: |
Nat Commun |
| Title: |
Inactivation of the Hippo tumor suppressor pathway promotes melanoma. |
| Volume: |
13 |
| Issue: |
1 |
| Pages: |
3732 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Marsh Durban V |
| Year: |
2013 |
| Journal: |
J Clin Invest |
| Title: |
Differential AKT dependency displayed by mouse models of BRAFV600E-initiated melanoma. |
| Volume: |
123 |
| Issue: |
12 |
| Pages: |
5104-18 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Dong B |
| Year: |
2022 |
| Journal: |
J Invest Dermatol |
| Title: |
FZD6 Promotes Melanoma Cell Invasion but Not Proliferation by Regulating Canonical Wnt Signaling and Epithelial‒Mesenchymal Transition. |
|
|
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Brighton HE |
| Year: |
2018 |
| Journal: |
Cancer Res |
| Title: |
New Mechanisms of Resistance to MEK Inhibitors in Melanoma Revealed by Intravital Imaging. |
| Volume: |
78 |
| Issue: |
2 |
| Pages: |
542-557 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Deuker MM |
| Year: |
2015 |
| Journal: |
Cancer Discov |
| Title: |
PI3'-kinase inhibition forestalls the onset of MEK1/2 inhibitor resistance in BRAF-mutated melanoma. |
| Volume: |
5 |
| Issue: |
2 |
| Pages: |
143-53 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Ho PC |
| Year: |
2014 |
| Journal: |
Cancer Res |
| Title: |
Immune-based antitumor effects of BRAF inhibitors rely on signaling by CD40L and IFNγ. |
| Volume: |
74 |
| Issue: |
12 |
| Pages: |
3205-17 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Nozawa A |
| Year: |
2024 |
| Journal: |
Hum Mol Genet |
| Title: |
Lymphatic endothelial cell-specific NRAS p.Q61R mutant embryos show abnormal lymphatic vessel morphogenesis. |
|
|
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Aktary Z |
| Year: |
2019 |
| Journal: |
Pigment Cell Melanoma Res |
| Title: |
Sequencing two Tyr::CreERT2 transgenic mouse lines. |
|
|
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Vial J |
| Year: |
2019 |
| Journal: |
Cell Death Differ |
| Title: |
The Ectodysplasin receptor EDAR acts as a tumor suppressor in melanoma by conditionally inducing cell death. |
| Volume: |
26 |
| Issue: |
3 |
| Pages: |
443-454 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Micevic G |
| Year: |
2016 |
| Journal: |
Cell Rep |
| Title: |
DNMT3b Modulates Melanoma Growth by Controlling Levels of mTORC2 Component RICTOR. |
| Volume: |
14 |
| Issue: |
9 |
| Pages: |
2180-2192 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Halaban R |
| Year: |
2016 |
| Journal: |
J Invest Dermatol |
| Title: |
RASopathy Gene Mutations in Melanoma. |
| Volume: |
136 |
| Issue: |
9 |
| Pages: |
1755-9 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Martens S |
| Year: |
2022 |
| Journal: |
Cell Death Dis |
| Title: |
MLKL deficiency in BrafV600EPten-/- melanoma model results in a modest delay of nevi development and reduced lymph node dissemination in male mice. |
| Volume: |
13 |
| Issue: |
4 |
| Pages: |
347 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sandell LL |
| Year: |
2011 |
| Journal: |
Genesis |
| Title: |
A phenotype-driven ENU mutagenesis screen identifies novel alleles with functional roles in early mouse craniofacial development. |
| Volume: |
49 |
| Issue: |
4 |
| Pages: |
342-59 |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cdkn2a/Cdkn2a Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Pten/Pten Tg(tetO-BRAF*V600E)29Lc/? Tg(Tyr-cre/ERT2)13Bos/? |
| Background: |
involves: 129/Sv * C57BL/6J * FVB * SJL |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Cdkn2a/Cdkn2a Nras/Nras Stk11/Stk11 Tg(Tyr-cre/ERT2)13Bos/? |
| Background: |
B6J.Cg-Tg(Tyr-cre/ERT2)13Bos Nras Cdkn2a Stk11 |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Ctnnb1/Ctnnb1 Tg(KRT14-rtTA)F42Efu/? Tg(tetO-EDN1,-lacZ)9Mhus/? Tg(Tyr-cre/ERT2)13Bos/? |
| Background: |
involves: C57BL/6J * FVB |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Mc1r/Mc1r Tg(KRT14-rtTA)F42Efu/? Tg(tetO-EDN1,-lacZ)9Mhus/? Tg(Tyr-cre/ERT2)13Bos/? |
| Background: |
involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac * FVB |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Braf/Braf<+> Ezh2/Ezh2<+> Tg(Tyr-cre/ERT2)13Bos/? |
| Background: |
involves: 129 * 129P2/OlaHsd * C57BL/6 * FVB |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Ezh2/Ezh2<+> Nras/Nras<+> Tg(Tyr-cre/ERT2)13Bos/? |
| Background: |
involves: 129 * 129P2/OlaHsd * C57BL/6 * FVB |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Genotype |
| Symbol: |
Gt(ROSA)26Sor/Gt(ROSA)26Sor Tg(Tyr-cre/ERT2)13Bos/? |
| Background: |
STOCK Tg(Tyr-cre/ERT2)13Bos Gt(ROSA)26Sor/Gt(ROSA)26Sor/Cvrk |
| Zygosity: |
cn |
| Has Mutant Allele: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Baruzzi A |
| Year: |
2010 |
| Journal: |
FEBS Lett |
| Title: |
c-Abl and Src-family kinases cross-talk in regulation of myeloid cell migration. |
| Volume: |
584 |
| Issue: |
1 |
| Pages: |
15-21 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kawai T |
| Year: |
1998 |
| Journal: |
Mol Cell Biol |
| Title: |
ZIP kinase, a novel serine/threonine kinase which mediates apoptosis. |
| Volume: |
18 |
| Issue: |
3 |
| Pages: |
1642-51 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kawai T |
| Year: |
1999 |
| Journal: |
Oncogene |
| Title: |
Death-associated protein kinase 2 is a new calcium/calmodulin-dependent protein kinase that signals apoptosis through its catalytic activity. |
| Volume: |
18 |
| Issue: |
23 |
| Pages: |
3471-80 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Jin Y |
| Year: |
2001 |
| Journal: |
J Biol Chem |
| Title: |
Identification of a new form of death-associated protein kinase that promotes cell survival. |
| Volume: |
276 |
| Issue: |
43 |
| Pages: |
39667-78 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
309
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Haegebarth A |
| Year: |
2004 |
| Journal: |
J Biol Chem |
| Title: |
The nuclear tyrosine kinase BRK/Sik phosphorylates and inhibits the RNA-binding activities of the Sam68-like mammalian proteins SLM-1 and SLM-2. |
| Volume: |
279 |
| Issue: |
52 |
| Pages: |
54398-404 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
377
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
38
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
52
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
299
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
373
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
41
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
291
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
119
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
108
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
44
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Attwood PV |
| Year: |
1995 |
| Journal: |
Int J Biochem Cell Biol |
| Title: |
The structure and the mechanism of action of pyruvate carboxylase. |
| Volume: |
27 |
| Issue: |
3 |
| Pages: |
231-49 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Jitrapakdee S |
| Year: |
1999 |
| Journal: |
Biochem J |
| Title: |
Structure, function and regulation of pyruvate carboxylase. |
| Volume: |
340 ( Pt 1) |
|
| Pages: |
1-16 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lietzan AD |
| Year: |
2013 |
| Journal: |
J Biol Chem |
| Title: |
A substrate-induced biotin binding pocket in the carboxyltransferase domain of pyruvate carboxylase. |
| Volume: |
288 |
| Issue: |
27 |
| Pages: |
19915-25 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Schnappauf G |
| Year: |
1998 |
| Journal: |
J Biol Chem |
| Title: |
Tyrosine and tryptophan act through the same binding site at the dimer interface of yeast chorismate mutase. |
| Volume: |
273 |
| Issue: |
27 |
| Pages: |
17012-7 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Klein C |
| Year: |
1991 |
| Journal: |
J Mol Biol |
| Title: |
Structure of cyclodextrin glycosyltransferase refined at 2.0 A resolution. |
| Volume: |
217 |
| Issue: |
4 |
| Pages: |
737-50 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chook YM |
| Year: |
1993 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Crystal structures of the monofunctional chorismate mutase from Bacillus subtilis and its complex with a transition state analog. |
| Volume: |
90 |
| Issue: |
18 |
| Pages: |
8600-3 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Gorman SD |
| Year: |
2019 |
| Journal: |
Biochemistry |
| Title: |
Energy and Enzyme Activity Landscapes of Yeast Chorismate Mutase at Cellular Concentrations of Allosteric Effectors. |
| Volume: |
58 |
| Issue: |
39 |
| Pages: |
4058-4069 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Griffith LC |
| Year: |
2003 |
| Journal: |
Mol Interv |
| Title: |
CaMKII, an enzyme on the move: regulation of temporospatial localization. |
| Volume: |
3 |
| Issue: |
7 |
| Pages: |
386-403 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Gangopadhyay SS |
| Year: |
2003 |
| Journal: |
Biochem J |
| Title: |
Differential functional properties of calmodulin-dependent protein kinase IIgamma variants isolated from smooth muscle. |
| Volume: |
372 |
| Issue: |
Pt 2 |
| Pages: |
347-57 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Rykx A |
| Year: |
2003 |
| Journal: |
FEBS Lett |
| Title: |
Protein kinase D: a family affair. |
| Volume: |
546 |
| Issue: |
1 |
| Pages: |
81-6 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kamei A |
| Year: |
2002 |
| Journal: |
DNA Res |
| Title: |
Biochemical examination of the potential eukaryotic-type protein kinase genes in the complete genome of the unicellular Cyanobacterium synechocystis sp. PCC 6803. |
| Volume: |
9 |
| Issue: |
3 |
| Pages: |
71-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Baylis SA |
| Year: |
1993 |
| Journal: |
J Virol |
| Title: |
African swine fever virus encodes a serine protein kinase which is packaged into virions. |
| Volume: |
67 |
| Issue: |
8 |
| Pages: |
4549-56 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yethon JA |
| Year: |
2001 |
| Journal: |
J Biol Chem |
| Title: |
Purification and characterization of WaaP from Escherichia coli, a lipopolysaccharide kinase essential for outer membrane stability. |
| Volume: |
276 |
| Issue: |
8 |
| Pages: |
5498-504 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kühner M |
| Year: |
2014 |
| Journal: |
Archaea |
| Title: |
The alternative route to heme in the methanogenic archaeon Methanosarcina barkeri. |
| Volume: |
2014 |
|
| Pages: |
327637 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Shani G |
| Year: |
2001 |
| Journal: |
EMBO J |
| Title: |
Autophosphorylation restrains the apoptotic activity of DRP-1 kinase by controlling dimerization and calmodulin binding. |
| Volume: |
20 |
| Issue: |
5 |
| Pages: |
1099-113 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Marcotte DJ |
| Year: |
2010 |
| Journal: |
Protein Sci |
| Title: |
Structures of human Bruton's tyrosine kinase in active and inactive conformations suggest a mechanism of activation for TEC family kinases. |
| Volume: |
19 |
| Issue: |
3 |
| Pages: |
429-39 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Mesci L |
| Year: |
2006 |
| Journal: |
Turk J Pediatr |
| Title: |
A novel mutation leading to a deletion in the SH3 domain of Bruton's tyrosine kinase. |
| Volume: |
48 |
| Issue: |
4 |
| Pages: |
362-4 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Vihinen M |
| Year: |
2000 |
| Journal: |
Front Biosci |
| Title: |
Bruton tyrosine kinase (BTK) in X-linked agammaglobulinemia (XLA). |
| Volume: |
5 |
|
| Pages: |
D917-28 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Brunner C |
| Year: |
2005 |
| Journal: |
Histol Histopathol |
| Title: |
Bruton's Tyrosine Kinase is involved in innate and adaptive immunity. |
| Volume: |
20 |
| Issue: |
3 |
| Pages: |
945-55 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Contreras CM |
| Year: |
2007 |
| Journal: |
Mol Immunol |
| Title: |
Btk regulates multiple stages in the development and survival of B-1 cells. |
| Volume: |
44 |
| Issue: |
10 |
| Pages: |
2719-28 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kang SW |
| Year: |
2001 |
| Journal: |
EMBO J |
| Title: |
PKCbeta modulates antigen receptor signaling via regulation of Btk membrane localization. |
| Volume: |
20 |
| Issue: |
20 |
| Pages: |
5692-702 |
|
•
•
•
•
•
|